Penumbra Inc. (PEN) Releases Q4 2025 Earnings: Revenue and EPS Beat, Strong YoY Growth

Penumbra Inc. ($PEN) reported fourth-quarter 2025 revenue of $385.4 million, up 22.1% year over year and ahead of the consensus estimate of $370.5 million.

Gross profit of $262.1 million (+24.4% YoY)

Operating profit of $59.2 million (+38.5% YoY)

Net income attributable to common shareholders of $45.9 million (+36.1% YoY)

Diluted earnings per share of $1.20 (+37.9% YoY)

Cost of sales of $123.3 million (+17.6% YoY)

Cash flow and balance sheet highlights:

Cash from operating activities: $58.3 million (+14.0% YoY)

Purchases of property, plant and equipment (capex): $16.2 million (up 202.5% YoY)

Cash and cash equivalents: $186.9 million (down 42.4% YoY)

Total liabilities: $398.9 million (+4.4% YoY)

The company exceeded analyst expectations on both revenue and earnings, reporting diluted EPS of $1.20 compared with an estimate of $1.12.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Penumbra Inc. Insider Trading Activity

Penumbra Inc. insiders have traded $PEN stock on the open market 55 times in the past 6 months. Of those trades, 0 have been purchases and 55 have been sales.

Here’s a breakdown of recent trading of $PEN stock by insiders over the last 6 months:

ARANI BOSE has made 0 purchases and 10 sales selling 30,000 shares for an estimated $9,062,929.
ADAM ELSESSER (CEO) has made 0 purchases and 4 sales selling 15,800 shares for an estimated $4,260,456.
JOHANNA ROBERTS (EVP, Gen. Counsel & Secretary) has made 0 purchases and 34 sales selling 4,500 shares for an estimated $1,279,469.
HARPREET GREWAL has made 0 purchases and 5 sales selling 844 shares for an estimated $226,647.
THOMAS WILDER has made 0 purchases and 2 sales selling 372 shares for an estimated $105,024.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Penumbra Inc. Hedge Fund Activity

We have seen 195 institutional investors add shares of Penumbra Inc. stock to their portfolio, and 309 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 759,723 shares (-12.9%) from their portfolio in Q4 2025, for an estimated $236,205,477
MILLENNIUM MANAGEMENT LLC added 444,526 shares (+190.5%) to their portfolio in Q4 2025, for an estimated $138,207,578
ARTISAN PARTNERS LIMITED PARTNERSHIP added 370,636 shares (+165.9%) to their portfolio in Q4 2025, for an estimated $115,234,438
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 345,974 shares (+inf%) to their portfolio in Q4 2025, for an estimated $107,566,776
NORGES BANK removed 338,001 shares (-76.1%) from their portfolio in Q4 2025, for an estimated $105,087,890
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 278,590 shares (-75.6%) from their portfolio in Q4 2025, for an estimated $86,616,416
SAMLYN CAPITAL, LLC added 212,956 shares (+inf%) to their portfolio in Q4 2025, for an estimated $66,210,149

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Penumbra Inc. Government Contracts

We have seen $120,441 of award payments to $PEN over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

PROSTHETICS:SURGICAL IMPLANTS COILS: $21,320
CONSIGNMENT AGREEMENT - RUBY COIL: $18,750
POST SURGERY-BILL ONLY CLINICIAN PRESCRIBED RUBY COIL EMBOLIZATION IMPLANTS FOR VETERAN PATIENT IAW 38 USC ...: $15,980
PROSTHETICS. SURGICAL IMPLANTS.: $15,580
CONSIGNMENT AGREEMENT - RUBY COIL: $13,190

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Penumbra Inc. Analyst Ratings

Wall Street analysts have issued reports on $PEN in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Truist Securities issued a "Buy" rating on 12/18/2025
Citigroup issued a "Buy" rating on 12/11/2025
Evercore ISI Group issued a "Outperform" rating on 10/07/2025

To track analyst ratings and price targets for Penumbra Inc., check out Quiver Quantitative's $PEN forecast page.

Penumbra Inc. Price Targets

Multiple analysts have issued price targets for $PEN recently. We have seen 13 analysts offer price targets for $PEN in the last 6 months, with a median target of $374.0.

Here are some recent targets:

Jason Mills from Canaccord Genuity set a target price of $374.0 on 01/20/2026
Shagun Singh from RBC Capital set a target price of $374.0 on 01/20/2026
Matthew Taylor from Jefferies set a target price of $374.0 on 01/16/2026
David Rescott from Baird set a target price of $374.0 on 01/16/2026
Joanne Wuensch from Citigroup set a target price of $374.0 on 01/16/2026
Ryan Zimmerman from BTIG set a target price of $349.0 on 01/16/2026
Mike Kratky from Leerink Partners set a target price of $374.0 on 01/16/2026